Trials / Terminated
TerminatedNCT00954148
Defining the Utility of PET/CT in the Follow-up of Patients With Solid Tumors
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Dallas VA Medical Center · Federal
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This is a comparison, at this VA Hospital,of routine multi-visit and multi-testing for solid tumor recurrence in four tumor groups to a limited scheduled 5 visit history/physical with PET/CT only, over a five year period. The purpose is to show through utilization of the single most sensitive and specific test currently available-PET/CT-that survival for patients in follow-up can be improved.(Plus lowering medical costs and increasing patient confidence and compliance with follow-up appointments).
Detailed description
Routine visits would include COLON:14 visits with cea and 6 CTs over a 5 year period plus PET/CT at last visit RECTAL: 14 visits with cea and 6 CTs and 4 procto exams over 5 year period plus PET/CT at last visit HEAD/NECK: 14 visits with 4 CTs and PET/CT at last visit LUNG:12 visits plus 4 CTs and PET/CT at last visit Limited follow-up ALL GROUPS: a history and physical plus PET/CT at 3 month, 9 month, 18 month, 36 month and 60 month only
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PET/CT | 5 visits with PET/CT as only testing |
| PROCEDURE | NCCN recommendations for solid tumor post treatment | 12-14 visits with exams, blood tests, CTs and PET/CT |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-05-01
- Completion
- 2010-06-01
- First posted
- 2009-08-07
- Last updated
- 2010-06-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00954148. Inclusion in this directory is not an endorsement.